Journal of Hematology Oncology Pharmacy

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e-Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Featured Articles

Editorial

Adoption of Biosimilars—Why the Delay?

Original Article

Comparing Single-Center Outcomes Between Reference and Biosimilar Granulocyte Colony-Stimulating Factor Drugs Used for Autologous Stem-Cell Mobilization

Original Article

Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials

Original Article

Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma

Symptom Management Overview

Vancomycin Infusion Reaction: A Clinical and Therapeutic Overview

Case Reports

Managing Resistant Fusarium Infections in Immunocompromised Pediatric Patients with Malignancy: 2 Case Reports and Review of the Literature

FDA Oncology Update

Kymriah Received Accelerated FDA Approval for Relapsed or Refractory Follicular Lymphoma

Tibsovo Received a New Indication, in Combination with Azacitidine, for Newly Diagnosed Patients with AML and IDH1 Mutation

Vidaza Received New Indication for Patients with Newly Diagnosed Juvenile Myelomonocytic Leukemia

Enhertu Received Regular FDA Approval for Patients with Unresectable or Metastatic Breast Cancer

Yescarta First CAR T-Cell Therapy FDA Approved for Large B-Cell Lymphoma

Pluvicto FDA Approved for PSMA-Positive Metastatic Prostate Cancer

Meeting Highlights

NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45

New Standards of Care for Melanoma

Genetic Score Makes PSA Screening More Accurate

First-Line Sotorasib Shows Long-Lasting Responses in Metastatic NSCLC with KRAS Mutation

Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer